Patents by Inventor Misako Yoneda

Misako Yoneda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10335481
    Abstract: It is an object of the present invention to provide a medicament or a pharmaceutical composition, which is effective for the treatment of various cancers. More specifically, the present invention relates to a pharmaceutical composition for use in the treatment of cancers, which comprises rMV-SLAM-blind or rMV-V(?)-SLAM-blind. The pharmaceutical composition has the effect of causing the regression of tumor, even if it is intravenously administered, and it also exhibits effects on cancer metastasized from a primary lesion.
    Type: Grant
    Filed: September 19, 2015
    Date of Patent: July 2, 2019
    Assignee: THE UNIVERSITY OF TOKYO
    Inventors: Chieko Kai, Misako Yoneda
  • Publication number: 20170340726
    Abstract: It is an object of the present invention to provide a medicament or a pharmaceutical composition, which is effective for the treatment of various cancers. More specifically, the present invention relates to a pharmaceutical composition for use in the treatment of cancers, which comprises rMV-SLAM-blind or rMV-V(?)-SLAM-blind. The pharmaceutical composition has the effect of causing the regression of tumor, even if it is intravenously administered, and it also exhibits effects on cancer metastasized from a primary lesion.
    Type: Application
    Filed: September 19, 2015
    Publication date: November 30, 2017
    Applicant: THE UNIVERSITY OF TOKYO
    Inventors: Chieko Kai, Misako Yoneda
  • Publication number: 20120321661
    Abstract: Provided herein is a vaccine which is safe and effective against malarial infection and a vector which is used in the manufacture of this vaccine and to provide a bivalent vaccine which exhibits an excellent preventive effect against measles virus and malarial infection and which eliminates complexity at the time of inoculation. Also provided is a recombinant measles virus in which is inserted a gene which encodes a protein involved in preventing malarial infection in the measles virus genome. The present invention also provides a bivalent vaccine against measles and malarial infection which contains the recombinant measles virus.
    Type: Application
    Filed: November 20, 2009
    Publication date: December 20, 2012
    Applicant: aRigen Pharmaceuticals, Inc.
    Inventors: Chieko Kai, Misako Yoneda
  • Publication number: 20120263751
    Abstract: Provided herein is a vaccine which is safe and effective against Nipah virus infection and a vector which is used in the manufacture of this vaccine and to provide a bivalent vaccine which exhibits an excellent preventive effect against measles virus and Nipah virus infection and which eliminates complexity at the time of inoculation. Also provided is a recombinant measles virus in which is inserted a gene which encodes a protein involved in preventing Nipah infection into the measles virus genome. The protein involved in preventing Nipah virus infection is preferably G protein or F protein which is a membrane protein. Also provided is a bivalent vaccine against measles and Nipah virus infection which contains the recombinant measles virus.
    Type: Application
    Filed: November 20, 2009
    Publication date: October 18, 2012
    Applicant: ARIGEN PHARMACEUTICALS, INC.
    Inventors: Chieko Kai, Misako Yoneda